The proposal would increase subsidies for a range of contraceptive options, consisting of the following components:

Component 1 – Remove the patient co-payment on Pharmaceutical Benefits Scheme (PBS) listed contraceptive items.

Component 2 – Cover the schedule fee for reproductive procedures.

Component 3 – Add a new Medicare Benefits Schedule (MBS) item for contraceptive counselling, including training for all prescribers.

Component 4 – Provide $250 million per year, ongoing, indexed by the Consumer Price Index (CPI), to make Therapeutic Goods Administration (TGA) approved non-PBS contraceptive items free.

The proposal would be ongoing and would start on 1 July 2025.